Zoll Medical Corporation, a manufacturer of medical devices and related software solutions, announced that RAV Gelderland-Midden in the Netherlands has equipped its fleet of 20 ambulances with the Zoll AutoPulse Non-invasive Cardiac Support Pump.


There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives. Automated injector systems not only precisely control the amount of contrast used; vendors have moved into the software/IT arena by offering personalized doses for patients using information pulled from an electronic medical record (EMR) or picture archiving and communication system (PACS). Contrast dose recording software also offers new possibilities for radiology departments looking to streamline and document their contrast media usage. Some vendors have now integrated X-ray radiation dose recording capabilities as well. 


Advanced visualization (AV) software and clinical applications are essential in the interpretation workflow of computed tomography (CT) and magnetic resonance imaging (MRI). In the last few years, the market success of new premium scanners has also hinged on the availability of wide-set clinical applications modules and image analytics tools, such as quantification, computer-assisted diagnosis and image fusion. 


Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Many patients hospitalized with severe heart failure are receiving potentially harmful treatment with intravenous fluids, a Yale-led study has found.

Younger adults with elevated systolic blood pressure have a higher risk for cardiovascular disease and coronary heart disease than those with normal blood pressure, according to a large long-term study of younger adults published online in the Journal of the American College of Cardiology. The risk was higher for women.

Medtronic announced the initiation of the Cryo4 Persistent AF (Cryoballoon Ablation for Early Persistent Atrial Fibrillation) clinical trial.

Swedish Medical Center is the first facility in the Rocky Mountain Region to implant a new miniaturized, wireless monitoring sensor to manage heart failure (HF).

Cleveland Clinic and AliveCor, Inc. announced the online publication of study results from Cleveland Clinic’s iTransmit Study, "Evaluating the Efficacy and Feasibility of a Novel Wireless Recording System Using Smartphone in Monitoring Patients After Atrial Fibrillation Ablation Procedure.”

Subscribe Now